Northwestern Memorial Hospital agreed to pay $3.3 million in damages after a jury determined a pharmaceutical error led to the overdose and death of a 56-year-old man.
Carolinas HealthCare System, North Carolina's largest healthcare provider, is asking a federal court to dismiss a U.S. Justice Department lawsuit alleging the system illegally imposes contract requirements on insurers that hinder competition.
The decision could potentially open the floodgates for more litigation tied to the device, which thousands of women have said led to chronic pelvic pain, punctured their uteruses and caused other damage.
Dr. Richard Anderson, CEO of the Doctors Co., a physician-owned medical malpractice insurer, discusses the challenges facing medical liability insurers and doctors amid increasing provider consolidation.
The Drug Enforcement Administration believes a Utah physician may have ties to an international drug cartel, and it wants access to the state's prescription drug monitoring program to continue its investigation.
A drug-trafficking investigation involving a Utah physician has privacy implications that could affect access to prescription drug record databases across the country.
Five retail pharmacies are suing Express Scripts for allegedly using its pharmacy benefit management business to pilfer billions of dollars of high-profit prescriptions and patients for its mail order pharmacy.
The way noncompete disputes play out in court varies from state to state, but some experts say judges are growing more comfortable enforcing them.
Penalties for each false claim submitted to programs such as Medicare will swell to a minimum of $10,781 from a current minimum of $5,500. The maximum will go up to $21,563 per false claim from a current maximum of $11,000.
South Carolina's Lexington Medical Center has agreed to a $17 million settlement over allegations that it paid 28 physicians unreasonably high amounts in exchange for referrals.
A federal judge in New York threw out nearly 1,300 lawsuits against Bayer over its Mirena intrauterine contraceptive device. The judge excluded expert testimony, feeling it would have been biased.
A federal judge said HHS showed a "cavalier disregard” for the truth and favoritism during the evaluation of bid proposals for its financial management system.